These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17453775)

  • 21. Right-sided vagus nerve stimulation in humans: an effective therapy?
    Spuck S; Nowak G; Renneberg A; Tronnier V; Sperner J
    Epilepsy Res; 2008 Dec; 82(2-3):232-4. PubMed ID: 18801642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conventional versus Delta valve in the treatment of hydrocephalus in early infancy.
    Kaiser GL; Horner E; Marchand S; Jost A
    Eur J Pediatr Surg; 1997 Dec; 7 Suppl 1():45-6. PubMed ID: 9497119
    [No Abstract]   [Full Text] [Related]  

  • 23. A retrospective analysis of the effects of magnet-activated stimulation in conjunction with vagus nerve stimulation therapy.
    Morris GL
    Epilepsy Behav; 2003 Dec; 4(6):740-5. PubMed ID: 14698710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Shunt malfunction causing acute neurological deterioration in 2 patients with previously asymptomatic Chiari malformation Type I. Report of two cases.
    Elliott R; Kalhorn S; Pacione D; Weiner H; Wisoff J; Harter D
    J Neurosurg Pediatr; 2009 Aug; 4(2):170-5. PubMed ID: 19645553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hardware failure in vagus nerve stimulation therapy.
    Rijkers K; Berfelo MW; Cornips EM; Majoie HJ
    Acta Neurochir (Wien); 2008 Apr; 150(4):403-5. PubMed ID: 18278574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transient atrial fibrillation after the implantation of a vagus nerve stimulator.
    Srinivasan B; Awasthi A
    Epilepsia; 2004 Dec; 45(12):1645. PubMed ID: 15571525
    [No Abstract]   [Full Text] [Related]  

  • 27. Progressive brainstem compression in an infant with neurocutaneous melanosis and Dandy-Walker complex following ventriculoperitoneal shunt placement for hydrocephalus. Case report.
    McClelland S; Charnas LR; SantaCruz KS; Garner HP; Lam CH
    J Neurosurg; 2007 Dec; 107(6 Suppl):500-3. PubMed ID: 18154021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resolution of hydrocephalus-associated sensorineural hearing loss after insertion of ventriculoperitoneal shunt.
    Sammons VJ; Jacobson E; Lawson J
    J Neurosurg Pediatr; 2009 Oct; 4(4):394-6. PubMed ID: 19795973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. From the anesthesiologist's perspective: placement of vagal nerve stimulator.
    Gerçek A; özek MM
    Anesth Analg; 2006 Jun; 102(6):1910. PubMed ID: 16717360
    [No Abstract]   [Full Text] [Related]  

  • 30. Misidentification of vagus nerve stimulator for intravenous access and other major adverse events.
    Pearl PL; Conry JA; Yaun A; Taylor JL; Heffron AM; Sigman M; Tsuchida TN; Elling NJ; Bruce DA; Gaillard WD
    Pediatr Neurol; 2008 Apr; 38(4):248-51. PubMed ID: 18358402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vagus stimulator for seizures.
    Rafael H; Moromizato P
    J Neurosurg; 1993 Oct; 79(4):636-7. PubMed ID: 8410239
    [No Abstract]   [Full Text] [Related]  

  • 32. Dural biopsy-- an important prognostic indicator in tuberculous meningitis with hydrocephalus following shunt surgery.
    Das SK; Ghosh D; Singhi A; Chattopadhyay S; Chatterjee N
    J Indian Med Assoc; 2007 Jan; 105(1):12-5. PubMed ID: 17802970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcome of ventriculoperitoneal shunt placement in Grade IV tubercular meningitis with hydrocephalus: a retrospective analysis in 95 patients. Clinical article.
    Srikantha U; Morab JV; Sastry S; Abraham R; Balasubramaniam A; Somanna S; Devi I; Bangalore CA; Pandey P
    J Neurosurg Pediatr; 2009 Aug; 4(2):176-83. PubMed ID: 19645554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical diagnosis of ventriculoperitoneal shunt failure among children with hydrocephalus.
    Piatt JH; Garton HJ
    Pediatr Emerg Care; 2008 Apr; 24(4):201-10. PubMed ID: 18431216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ventriculo cholecystic shunt in the management of hydrocephalus.
    Pal K; Jindal V
    Indian Pediatr; 2007 Jun; 44(6):435-7. PubMed ID: 17620698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of effects of vagus nerve stimulation on drug-resistant epilepsy in eight pediatric patients with autism spectrum disorders: a prospective 2-year follow-up study.
    Danielsson S; Viggedal G; Gillberg C; Olsson I
    Epilepsy Behav; 2008 Feb; 12(2):298-304. PubMed ID: 18053767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of Doppler USG and CSF flow wave patterns in the diagnosis of ventriculoperitoneal shunt obstructions.
    Kaplan M; Yakar H; Orhan H; Erol FS
    Pediatr Neurosurg; 2007; 43(6):468-71. PubMed ID: 17992034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Facial diplegia revealing ventriculoperitoneal shunt failure in a patient with Crouzon syndrome. Case report.
    Thines L; Vinchon M; Lahlou A; Pellerin P; Dhellemmes P
    J Neurosurg; 2007 Jul; 107(1 Suppl):46-8. PubMed ID: 17644920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vagus nerve stimulation for the treatment of intractable epilepsy.
    Amar AP
    Expert Rev Neurother; 2007 Dec; 7(12):1763-73. PubMed ID: 18052768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Akinetic mutism and magnetic resonance imaging in obstructive hydrocephalus. Case illustration.
    Abekura M
    J Neurosurg; 1998 Jan; 88(1):161. PubMed ID: 9420094
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.